PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview.
Fahmi
Hassan
H
Pelletier
Jean-Pierre
JP
Martel-Pelletier
Johanne
J
D000818:Animals; D001168:Arthritis / Q000276:immunology / Q000378:metabolism* / Q000503:physiopathology; D051546:Cyclooxygenase 2; D015777:Eicosanoids / Q000378:metabolism; D004734:Energy Metabolism / Q000502:physiology*; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology / Q000378:metabolism*; D007527:Isoenzymes / Q000378:metabolism; D008024:Ligands; D008565:Membrane Proteins; D009000:Monocytes / Q000378:metabolism; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D013583:Synovial Membrane / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism*
D015777:Eicosanoids; D005227:Fatty Acids; D018836:Inflammation Mediators; D007527:Isoenzymes; D008024:Ligands; D008565:Membrane Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases